Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction
- PMID: 25216368
- PMCID: PMC4197404
- DOI: 10.1002/mds.26012
Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction
Abstract
The clinical syndrome of Huntington's disease (HD) is notable for a triad of motor, cognitive, and emotional features. All HD patients eventually become occupationally disabled; however, the factors that render HD patients unable to maintain employment have not been extensively studied. This review begins by discussing the clinical triad of HD, highlighting the distinction in the motor disorder between involuntary movements, such as chorea, and voluntary movement impairment, with the latter contributing more to functional disability. Cognitive disorder clearly contributes to disability, though the relative contribution compared to motor is difficult to unravel, especially because many of the tests used to asses "cognition" have a strong motor component. The role of emotional changes in disability needs more study. The literature on contributions to functional disability, driving impairment, and nursing home placement is reviewed. Relevant experience is presented from the long-standing JHU HD observational study on motor versus cognitive onset, as well as on cognitive and motor features at the time when individuals discontinued working. Finally, we briefly review government policies in several countries on disability determination. We interpret the data from our own studies and from the literature to indicate that there is usually a close relationship between cognitive and motor dysfunction, and that it is critical to take both into consideration in determining disability. © 2014 International Parkinson and Movement Disorder Society.
Keywords: CAG repeat; Chorea; driving; motor impairment.
© 2014 International Parkinson and Movement Disorder Society.
Figures


References
-
- Walker FO. Huntington’s disease. Lancet. 2007;369(9557):218–228. - PubMed
-
- Ross CA, Tabrizi SJ. Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet neurology. 2011;10(1):83–98. - PubMed
-
- Ross CA, Aylward EH, Wild EJ, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature reviews Neurology. 2014;10(4):204–216. - PubMed
-
- Folstein SE. The psychopathology of Huntington’s disease. Research publications - Association for Research in Nervous and Mental Disease. 1991;69:181–191. - PubMed
-
- Folstein SE. Huntington’s disease: a disorder of families. Baltimore: Johns Hopkins University Press; 1989.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical